Horizon Pharma (HZNP) Tops Q3 EPS by 15c, Offers Guidance
Tweet Send to a Friend
Horizon Pharma (NASDAQ: HZNP) reported Q3 EPS of $0.64, $0.15 better than the analyst estimate of $0.49 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
